Sumatriptan/naproxen explained

Type:combo
Component1:Sumatriptan
Class1:Triptan
Component2:Naproxen
Class2:Nonsteroidal anti-inflammatory drug (NSAID)
Tradename:Treximet, Suvexx, others
Dailymedid:Sumatriptan naproxen
Routes Of Administration:By mouth
Atc Prefix:N02
Atc Suffix:CC51
Legal Ca:Rx-only
Legal Ca Comment:[1]
Legal Us:Rx-only
Legal Us Comment:[2]
Kegg:D11577

Sumatriptan/naproxen, sold under the brand name Treximet among others, is a fixed-dose combination medication used to treat migraines. It is taken by mouth. It contains sumatriptan, as the succinate, a serotonin 5-hydroxytryptamine (5-HT) 1b/1d receptor agonist (triptan); and naproxen as the sodium salt, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs).

Medical uses

Sumatriptan/naproxen is indicated for the acute treatment of migraine with or without aura in people twelve years of age and older.

A Cochrane review in 2020 found that the combination of sumatriptan plus naproxen was better than placebo for relieving acute migraine attacks in adults. When the starting headache intensity was mild, 5 in 10 (50%) of people treated with the combination were pain-free at two hours compared with about 2 in 10 (18%) with placebo. Almost 6 in 10 (58%) people with moderate or severe pain who were treated with the combination had pain reduced to mild or none at two hours, compared with 3 in 10 (27%) with placebo. The combination was also better than the same dose of either drug given alone in these people. Results were 5 in 10 (52%) people with sumatriptan alone or about 4 in 10 (44%) with naproxen alone.[3]

Side effects

Some of the listed side effects include dizziness, nausea, sleepiness, dry mouth, pain in neck, throat or jaw, numbness or tingling.[4]

External links

Notes and References

  1. Web site: Regulatory Decision Summary - Suvexx . Health Canada . 23 October 2014 . 7 June 2022.
  2. Web site: Treximet- sumatriptan succinate and naproxen sodium tablet, film coated . DailyMed . 14 April 2022 . 7 June 2022.
  3. Law S, Derry S, Moore RA . Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults . The Cochrane Database of Systematic Reviews . 4 . 4 . CD008541 . April 2016 . 27096438 . 10.1002/14651858.CD008541.pub3 . 6485397 .
  4. Web site: Treximet . Drugs.com .